Literature DB >> 11983200

Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.

Anthony J Janckila1, David H Neustadt, Yuri R Nakasato, Jussi M Halleen, Teuvo Hentunen, Lung T Yam.   

Abstract

OBJECTIVES: Our objective was to evaluate the significance and source of serum tartrate-resistant acid phosphatase (TRACP) in patients with rheumatoid arthritis (RA).
METHODS: Thirty-five RA, 32 osteoarthritis (OA) and 16 control subjects were studied. Serum TRACP-5b activity and total TRACP protein were determined by immunoassay. TRACP isoforms were analyzed by non-denaturing polyacrylamide gel electrophoresis (PAGE). Serum bone alkaline phosphatase (BAP), cross-linked N-terminal telopeptides (NTx), and C-terminal telopeptides (ICTP) of type I collagen were estimated as markers of bone turnover. C-reactive protein (CRP) was measured as a marker of chronic inflammation. Macrophages and dendritic cells (DC) were developed from peripheral blood monocytes. Cell lysates and culture supernatants were analyzed for TRACP isoforms by immunoassay and PAGE.
RESULTS: In RA, mean TRACP-5b activity was normal, but median total TRACP protein was increased twofold (p<0.001). In OA, TRACP-5b activity and protein were normal. In RA, TRACP-5b activity correlated weakly with ICTP (r=0.56) while TRACP protein levels correlated weakly with NTx (r=0.43). Additionally, TRACP protein, but not TRACP-5b activity correlated significantly with CRP (r=0.42). Macrophage and DC lysates contained TRACP-5b, while tissue culture supernatants contained TRACP-5a.
CONCLUSIONS: Increased total TRACP protein in RA sera was probably due to TRACP-5a and not derived from osteoclasts. Rather, it could be a secreted product of inflammatory macrophages and DC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983200     DOI: 10.1016/s0009-8981(02)00026-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Severe nutritional iron-deficiency anaemia has a negative effect on some bone turnover biomarkers in rats.

Authors:  Javier Díaz-Castro; Mercedes Ramírez López-Frías; Margarita S Campos; Magdalena López-Frías; María J M Alférez; Teresa Nestares; María L Ojeda; Inmaculada López-Aliaga
Journal:  Eur J Nutr       Date:  2011-06-07       Impact factor: 5.614

2.  The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts.

Authors:  Su Huang; Pierre P Eleniste; Kornchanok Wayakanon; Prashant Mandela; Betty A Eipper; Richard E Mains; Matthew R Allen; Angela Bruzzaniti
Journal:  Bone       Date:  2013-12-28       Impact factor: 4.398

3.  Intensive weight gain therapy in patients with anorexia nervosa results in improved serum tartrate-resistant acid phosphatase (TRAP) 5a and 5b isoform protein levels.

Authors:  Christina Patlaka; Bojan Tubic; Pernilla Lång; Staffan Paulie; Diana Swolin-Eide; Per Magnusson; Göran Andersson
Journal:  Eat Weight Disord       Date:  2019-09-17       Impact factor: 4.652

4.  Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients treated with bisphosphonates alone or in combination with pitavastatin over an 18-month follow-up after more than 4 years of treatment with bisphosphonates.

Authors:  Masakazu Nagashima; Hiroshi Takahashi; Kenichi Shimane; Yuichi Nagase; Koichi Wauke
Journal:  Arthritis Res Ther       Date:  2012-10-18       Impact factor: 5.156

5.  Serum Heme Oxygenase-1 and BMP-7 Are Potential Biomarkers for Bone Metabolism in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.

Authors:  Tong-Ling Yuan; Jin Chen; Yan-Li Tong; Yan Zhang; Yuan-Yuan Liu; James Cheng-Chung Wei; Yi Liu; Yi Zhao; Martin Herrmann
Journal:  Biomed Res Int       Date:  2016-05-26       Impact factor: 3.411

Review 6.  Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment.

Authors:  Cathleen Drescher; Masaaki Konishi; Nicole Ebner; Jochen Springer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-11-18       Impact factor: 12.910

7.  In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice.

Authors:  Qin Shi; Elsa-Patricia Rondon-Cavanzo; Isadora Pfeifer Dalla Picola; Marcio José Tiera; Xiaoling Zhang; Kerong Dai; Houda Abir Benabdoune; Mohamed Benderdour; Julio Cesar Fernandes
Journal:  Int J Nanomedicine       Date:  2018-01-12

8.  Locking plate osteosynthesis for a femoral fracture and subsequent nonunion in a patient with osteopetrosis.

Authors:  Tomoya Matsuo; Sang Yang Lee; Takashi Iwakura; Tomoaki Fukui; Keisuke Oe; Tomoyuki Matsumoto; Takehiko Matsushita; Kotaro Nishida; Ryosuke Kuroda; Takahiro Niikura
Journal:  Int J Surg Case Rep       Date:  2018-09-17

9.  Association of Tartrate-Resistant Acid Phosphatase-Expressed Macrophages and Metastatic Breast Cancer Progression.

Authors:  Yu-Guang Chen; Anthony Janckila; Tsu-Yi Chao; Ren-Hua Yeh; Hong-Wei Gao; Su-Huei Lee; Jyh-Cherng Yu; Guo-Shiou Liao; Ming-Shen Dai
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.